Loading
Latest filing published 12 Mar 2026 for 비보존 제약, €434. Read the official filing
No signal scores available.
Not enough history yet: 1 closed purchase, at least 2 are needed.
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
All filings by 이지연 on record concern 비보존 제약, in the capacity of senior executive. In total, 2 filings cover trades dated from 30 January 2026 to 5 March 2026.
Purchases make up the whole of the open-market record (2 purchases, €434). The amount is not disclosed for 1 filing. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay.
The newest entry dates from 12 March 2026: an open-market purchase of €434, in 비보존 제약. Source: insider filings from DART (FSS). Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.